CRISPR-Cas9 correction of OPA1 c.1334G>A: p.R445H restores
Por um escritor misterioso
Descrição
Overview of placebo-controlled idebenone trial in BL/6-Opa1 +/À
Optic Atrophy 1 Controls Human Neuronal Development by Preventing
Optic Atrophy 1 Controls Human Neuronal Development by Preventing
CRISPR-AsCas12a Efficiently Corrects a GPR143 Intronic Mutation in
CRISPR/Cas9-Mediated Gene Correction in Osteopetrosis Patient
OPA1 Mutation and Late‐Onset Cardiomyopathy: Mitochondrial
LambaLab (@LabLamba) / X
CRISPR/Cas9-mediated A4GALT suppression rescues Fabry disease
Functional genomics and the future of iPSCs in disease modeling
Homology directed correction, a new pathway model for point
IJMS, Free Full-Text
Characterisation of a novel OPA1 splice variant resulting in
PDF) CRISPR/Cas9 correction of OPA1 c.1334G>A: p.R445H restores
High‐throughput screening identifies suppressors of mitochondrial
de
por adulto (o preço varia de acordo com o tamanho do grupo)
